Catchpole M A
Communicable Disease Surveillance Centre, London, UK.
Genitourin Med. 1996 Oct;72(5):321-9. doi: 10.1136/sti.72.5.321.
Surveillance and epidemiological studies are essential components of effective control programmes for sexually transmitted diseases. While other forms of basic biomedical research may add to our understanding of why an exposure or behaviour causes or prevents disease, only epidemiology allows the quantification of the magnitude of the exposure-disease relationship in humans. It is this measure of the association between risk and disease that is needed to inform rational policy on altering risk through intervention. Surveillance data are used both to determine the need for public health action and to assess the effectiveness of programmes: they are required for the setting of priorities, for planning and resource allocation, for the definition of population subgroups and risky behaviours for targeted interventions, for the development of disease prevention programmes, and for the evaluation of interventions. Data from surveillance systems and epidemiological studies can also inform diagnostic and therapeutic practice, and indicate areas for further research. Over the last 20 years chlamydia infections and viral agents have emerged as the major cause of STD in developed countries, and with this change in the aetiological mix of STD cases the focus of prevention and control of STDs has shifted from treatment and partner notification towards health education. In developing countries there is an urgent need for appropriate surveillance infrastructures, particularly now that there is evidence that STD control programmes, informed by surveillance data, can reduce HIV transmission at the population level. The importance of surveillance and epidemiology in the control of STDs is set to increase in the face of the changing pattern of sexually transmitted pathogens. The challenge to clinicians and epidemiologists is to work together in developing systems that will inform new approaches to control and prevention.
监测和流行病学研究是性传播疾病有效防控计划的重要组成部分。虽然其他形式的基础生物医学研究可能会增进我们对某种暴露或行为为何会导致或预防疾病的理解,但只有流行病学能够量化人类中暴露与疾病关系的程度。正是这种对风险与疾病之间关联的衡量,才是制定通过干预改变风险的合理政策所必需的。监测数据既用于确定公共卫生行动的必要性,也用于评估项目的有效性:它们对于确定优先事项、规划和资源分配、定义目标干预的人群亚组和危险行为、制定疾病预防项目以及评估干预措施都是必需的。监测系统和流行病学研究的数据还可为诊断和治疗实践提供信息,并指出进一步研究的领域。在过去20年中,衣原体感染和病毒病原体已成为发达国家性传播疾病的主要病因,随着性传播疾病病例病因组合的这种变化,性传播疾病的预防和控制重点已从治疗和通知性伴转向健康教育。在发展中国家,迫切需要适当的监测基础设施,特别是现在有证据表明,基于监测数据的性传播疾病防控项目能够在人群层面减少艾滋病毒传播。面对性传播病原体模式的变化,监测和流行病学在性传播疾病控制中的重要性必将增加。临床医生和流行病学家面临的挑战是共同努力开发能够为新的控制和预防方法提供信息的系统。